Provider fact sheet · dataset v2026.08.14-4 · last touched 2026-08-14
MEDVi: GLP-1 programs, prices, and verification status (2026)
MEDVi is a unverified entry in our universe. The lowest independently reported injectable entry price we track, from ~$199 at starting doses.
Programs and pricing, in plain sentences
tirzepatide (injection) — status: unverified. Key fields: price rises with dose. Reported lowest injectable entry price at 2.5-5 mg starting doses; maintenance-dose figure pending
Every figure above carries its status — operator claims come from the provider, reported from third parties we cite, verified only after our own checkout walk. Machine-readable version: providers.json.
Update — August 14, 2026: Verified at its cited source: the April 2026 tirzepatide.us.com comparison confirms $199/mo starting ("Editor's Choice" there — an affiliate placement, disclosed on that site, which we weight accordingly). Its hidden-costs section adds a useful detail: MEDVi typically waives the consult fee for subscribers. Maintenance-dose pricing remains the open item.
Verification status and open items
Current status: unverified, last touched 2026-08-14. Open verification items: dispensing pharmacy identity, state coverage map, cancellation terms. Source on file: tirzepatide.us.com. Corrections land within 48 hours via the public log — if your checkout contradicts this page, that report changes the dataset.
How MEDVi fits the market
The lowest independently reported injectable entry price we track, from ~$199 at starting doses. The open question that decides its real ranking: what maintenance doses cost, which no third-party source we accept has confirmed. Until then it holds the 'reported' band with an asterisk exactly where your month-six budget lives. Where it lands overall: the price ladder, the category winners, and the program finder all compute from the same dataset this page renders.
Advertising disclosure: outbound provider links may be commission-bearing; our partner relationship with NexLife is disclosed on the ownership page and never alters statuses or rankings.